Wikidata

(Q113888311)

English

Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
Comparative Effecacy of Metformin and Vildagliptin on Cardiometabolic Risk Factors, Metabolic Syndrome, and Diabetic Nephropathy Progression (English)
0 references
country
Egypt
0 references
start time
1 November 2019
0 references
end time
30 August 2020
0 references
number of participants
39
0 references
research intervention
metformin
0 references
vildagliptin
0 references
captopril
0 references
enzyme inhibitor
0 references
mechanism of action
0 references
ACE inhibitor
0 references
antihypertensive drug
0 references
minimum age
40 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q113888311&oldid=2149426318"